2020

1. Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries

   American Heart Journal, Vol. 220, pp. 108-115

2. Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor

   International Journal of Cardiology, Vol. 301, pp. 200-206

3. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry

   European Journal of Preventive Cardiology, Vol. 27, Núm. 7, pp. 696-705

4. P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects

   European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42